- Home
- GDEV vs RNAC Comparison
GDEV vs RNAC Comparison
Compare GDEV & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEV
- RNAC
- Stock Information
- Founded
- GDEV 2009
- RNAC 2007
- Country
- GDEV Cyprus
- RNAC United States
- Employees
- GDEV N/A
- RNAC N/A
- Industry
- GDEV EDP Services
- RNAC Biotechnology: Pharmaceutical Preparations
- Sector
- GDEV Technology
- RNAC Health Care
- Exchange
- GDEV Nasdaq
- RNAC Nasdaq
- Market Cap
- GDEV 384.5M
- RNAC 282.6M
- IPO Year
- GDEV N/A
- RNAC 2016
- Fundamental
- Price
- GDEV $14.56
- RNAC $13.39
- Analyst Decision
- GDEV Buy
- RNAC Strong Buy
- Analyst Count
- GDEV 1
- RNAC 5
- Target Price
- GDEV $70.00
- RNAC $40.00
- AVG Volume (30 Days)
- GDEV 11.4K
- RNAC 79.8K
- Earning Date
- GDEV 09-03-2025
- RNAC 08-07-2025
- Dividend Yield
- GDEV N/A
- RNAC N/A
- EPS Growth
- GDEV N/A
- RNAC N/A
- EPS
- GDEV 1.38
- RNAC N/A
- Revenue
- GDEV $420,933,000.00
- RNAC $34,173,000.00
- Revenue This Year
- GDEV N/A
- RNAC N/A
- Revenue Next Year
- GDEV $17.39
- RNAC N/A
- P/E Ratio
- GDEV $11.16
- RNAC N/A
- Revenue Growth
- GDEV N/A
- RNAC 31.91
- 52 Week Low
- GDEV $8.60
- RNAC $8.46
- 52 Week High
- GDEV $42.76
- RNAC $26.50
- Technical
- Relative Strength Index (RSI)
- GDEV 44.55
- RNAC 61.35
- Support Level
- GDEV $15.26
- RNAC $12.81
- Resistance Level
- GDEV $17.60
- RNAC $13.75
- Average True Range (ATR)
- GDEV 1.03
- RNAC 1.03
- MACD
- GDEV -0.14
- RNAC 0.25
- Stochastic Oscillator
- GDEV 17.96
- RNAC 50.90
About GDEV GDEV Inc.
GDEV Inc is a gaming and entertainment holding company that oversees a portfolio of studios focused on developing and publishing live-service games across a range of platforms and genres. Its portfolio includes studios specializing in mobile, browser, and PC games, as well as captivating IPs spanning various genres.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.